post-symptomatic, time of injection is a highly significant factor in the efficacy of treatment, and in this study, demonstrating that this is true not only for ICV delivery but also for systemic delivery.
← all excerpts
Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1.
1
—
—